PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Pharma-Bio Serv, Inc.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$0.48+0.08 (+20.00%)
Close on Oct 19, 2026
- Market cap
- $11.00M
- P/E (TTM)
- 48.0
- Dividend yield
- –
Pharma-Bio Serv, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Puerto Rico Consulting [Member] | $1.37M | $1.45M | $1.16M | $1.16M | $1.20M | $1.17M | $1.10M | $1.38M | $1.45M | $1.46M | $1.39M | $1.90M | 58.6% | +13.6% |
| United States Consulting [Member] | $740.00K | $619.78K | $546.89K | $617.33K | $642.86K | $714.10K | $646.13K | $739.44K | $737.28K | $802.55K | $882.89K | – | 31.7% | +15.1% |
| Europe Consulting [Member] | $228.23K | $625.63K | $583.90K | $374.20K | $98.98K | $532.70K | $721.26K | $211.18K | $224.36K | $70.84K | $64.81K | $527.28K | 9.8% | +130.6% |
| Other Segment [Member] | $0 | $6.56K | $0 | – | $17.59K | $0 | $673 | $0 | $2.33K | $41.57K | $41.88K | $0 | 0.0% | -100.0% |
| United States | – | – | – | – | – | – | – | – | $737.28K | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Pharma-Bio Serv's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.